Transcend Capital Advisors, LLC Novartis Ag Transaction History

Transcend Capital Advisors, LLC

  • $1.39 Billion
  • Q1 2025

A detailed history of Transcend Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 10,402 shares of NVS stock, worth $1.17 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,402
Previous 10,388 0.13%
Holding current value
$1.17 Million
Previous $1.01 Million 14.75%
% of portfolio
0.08%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 24, 2025
BUY
$97.14 - $115.57 $1,359 - $1,617
14 Added 0.13%
10,402 $1.16 Million
Q4 2024

Feb 03, 2025
SELL
$96.78 - $117.18 $4,355 - $5,273
-45 Reduced 0.43%
10,388 $1.01 Million
Q3 2024

Oct 15, 2024
SELL
$106.13 - $120.89 $78,536 - $89,458
-740 Reduced 6.62%
10,433 $1.2 Million
Q2 2024

Jul 02, 2024
SELL
$92.57 - $107.37 $4,350 - $5,046
-47 Reduced 0.42%
11,173 $1.19 Million
Q1 2024

May 03, 2024
SELL
$95.27 - $108.47 $9,527 - $10,847
-100 Reduced 0.88%
11,220 $1.09 Million
Q4 2023

Feb 05, 2024
SELL
$92.27 - $101.54 $17,715 - $19,495
-192 Reduced 1.67%
11,320 $1.14 Million
Q3 2023

Oct 31, 2023
SELL
$94.73 - $105.13 $54,280 - $60,239
-573 Reduced 4.74%
11,512 $1.17 Million
Q2 2023

Jul 13, 2023
BUY
$92.52 - $104.91 $15,635 - $17,729
169 Added 1.42%
12,085 $1.22 Million
Q1 2023

Apr 12, 2023
SELL
$80.03 - $92.81 $37,293 - $43,249
-466 Reduced 3.76%
11,916 $1.1 Million
Q4 2022

Jan 20, 2023
SELL
$75.55 - $92.52 $17,905 - $21,927
-237 Reduced 1.88%
12,382 $0
Q3 2022

Oct 17, 2022
SELL
$74.61 - $87.26 $10,893 - $12,739
-146 Reduced 1.14%
12,619 $959,000
Q2 2022

Jul 12, 2022
SELL
$80.52 - $93.75 $75,849 - $88,312
-942 Reduced 6.87%
12,765 $1.08 Million
Q1 2022

Apr 20, 2022
BUY
$80.11 - $90.62 $32,764 - $37,063
409 Added 3.08%
13,707 $1.2 Million
Q4 2021

Jan 20, 2022
BUY
$79.7 - $88.13 $113,652 - $125,673
1,426 Added 12.01%
13,298 $1.16 Million
Q3 2021

Nov 04, 2021
BUY
$81.78 - $95.14 $970,892 - $1.13 Million
11,872 New
11,872 $1.01 Million
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $1.02 Million - $1.13 Million
-12,003 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$83.5 - $98.47 $32,899 - $38,797
-394 Reduced 3.18%
12,003 $1.03 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $46,217 - $55,902
592 Added 5.01%
12,397 $1.17 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $36,059 - $39,949
439 Added 3.86%
11,805 $1.03 Million
Q2 2020

Aug 05, 2020
SELL
$80.93 - $91.1 $225,713 - $254,077
-2,789 Reduced 19.7%
11,366 $993,000
Q1 2020

May 08, 2020
SELL
$70.67 - $99.01 $36,607 - $51,287
-518 Reduced 3.53%
14,155 $1.17 Million
Q4 2019

Feb 19, 2020
BUY
$84.35 - $95.37 $1.24 Million - $1.4 Million
14,673 New
14,673 $1.39 Million

Others Institutions Holding NVS

# of Institutions
1,523
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $243B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email